Tested Applications
| Positive WB detected in | HEK-293 cells, HeLa cells, HepG2 cells, MCF-7 cells |
| Positive IP detected in | HeLa cells |
| Positive IHC detected in | human breast cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:1000-1:6000 |
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunohistochemistry (IHC) | IHC : 1:200-1:800 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
20366-1-AP targets SUZ12 in WB, IHC, IP, CoIP, ELISA applications and shows reactivity with human, rat samples.
| Tested Reactivity | human, rat |
| Cited Reactivity | human, mouse, rat |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
Peptide Predict reactive species |
| Full Name | suppressor of zeste 12 homolog (Drosophila) |
| Calculated Molecular Weight | 83 kDa |
| Observed Molecular Weight | 80-90 kDa |
| GenBank Accession Number | NM_015355 |
| Gene Symbol | SUZ12 |
| Gene ID (NCBI) | 23512 |
| RRID | AB_10694152 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q15022 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
SUZ12, also termed CHET9, JJAZ1 or KIAA0160, belongs to the VEFS (VRN2-EMF2-FIS2-SU(Z)12) family. It is a polycomb group (PcG) protein. SUZ12 is a component of the PRC2/EED-EZH2 complex, which methylates 'Lys-9' and 'Lys-27' of histone H3, leading to transcriptional repression of the affected target gene. The PRC2/EED-EZH2 complex may also serve as a recruiting platform for DNA methyltransferases, thereby linking two epigenetic repression systems. Genes repressed by the PRC2/EED-EZH2 complex include HOXC8, HOXA9, MYT1 and CDKN2A. A chromosomal aberration involving SUZ12 may be a cause of endometrial stromal tumors.
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for SUZ12 antibody 20366-1-AP | Download protocol |
| IP protocol for SUZ12 antibody 20366-1-AP | Download protocol |
| WB protocol for SUZ12 antibody 20366-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The SUZ12 Polyclonal antibody (Cat# 20366-1-AP) has 21 citations. These appear in journals including Nature Communications, Molecular Cancer, Molecular Cell, EMBO Journal, Journal of Experimental & Clinical Cancer Research, Advanced Science, Cell Death & Disease, International Journal of Biological Sciences, Acta Pharmacologica Sinica, European Journal of Medicinal Chemistry, Cell & Molecular Life Sciences, Frontiers in Pharmacology, Inflammation, mSystems, Scientific Reports, Translational Oncology, Cell Signaling, American Journal of Cancer Research, and Photochemistry & Photobiology. Research fields span epigenetics (PRC2/EZH2), cancer (ovarian, colon, bladder, breast, lung, glioblastoma), senescence, and inflammation.
| Species | Application | Title |
|---|---|---|
Mol Cancer Cell surface CD55 traffics to the nucleus leading to cisplatin resistance and stemness by inducing PRC2 and H3K27 trimethylation on chromatin in ovarian cancer | ||
Nat Commun Phosphorylation and stabilization of EZH2 by DCAF1/VprBP trigger aberrant gene silencing in colon cancer | ||
Mol Cell TRACE generates fluorescent human reporter cell lines to characterize epigenetic pathways.
| ||
Mol Cell CRAMP1 drives linker histone expression to enable Polycomb repression
| ||
J Exp Clin Cancer Res EIF4A3-mediated biogenesis of circSTX6 promotes bladder cancer metastasis and cisplatin resistance | ||
Adv Sci (Weinh) The Interplay Between HIF-1α and EZH2 in Lung Cancer and Dual-Targeted Drug Therapy |
Reviews
What customers say
Able is busy answering your previous question. Please try again later.
The reviews below have been submitted by verified Proteintech customers who received an incentive for providing their feedback.
Nikhil (Verified Customer) (01-07-2022) | HCT116 whole cell extract, 20micro/lane. Lane 2-4 transient expression of EZH2
![]() |




















